Leadership
NovMetaPharma focuses on the R&D of new drugs through core domestic and international research teams.
ABOUT NOVMETAPHARMA
NovMetaPharma is a company that specialized in developing first-in-class drugs with differentiated mechanisms related to metabolic disease. We will lead the global market for treating metabolic diseases through ingenious technology and efficient development systems.
Pipelines
NoveMetaPharma focuses its main pipeline on addressing patients’ unmet medical needs.
Publications
NoveMetaPharma continuously advances its research with dedication and focus.